The New York Entrepreneur

J&J lowers 2022 revenue and earnings expectations, stops giving Covid vaccine sales guidance

Read Time:9 Second

When asked about halting guidance for J&J’s Covid vaccine, CFO Joe Wolk said the shots are not for profit and do not impact the company’s bottom line.

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %
Previous post Netflix shares crater 25% after company reports it lost subscribers for the first time in more than 10 years
Next post ‘Don’t fight the U.S. consumer’ — Bank of America CEO says spending is healthy despite roaring inflation